RA Low Disease Activity (DAS28) Medication Savings with TheDrugClub
Discount pricing may be available. Current formulary eligibility is being verified; a condition association does not establish FREE coverage.
- Join TheDrugClub as a member
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
About RA Low Disease Activity (DAS28)
Understanding Rheumatoid Arthritis (RA) low disease activity, as measured by a DAS28 score, is key to effective management. Even at this stage, consistent treatment is vital to prevent progression and flares. TheDrugClub helps patients afford necessary RA medications, ensuring continuity of care without financial strain.
Rheumatoid Arthritis (RA) is a chronic autoimmune condition where the body's immune system mistakenly attacks its own tissues, primarily affecting the joints. This can lead to pain, swelling, stiffness, and eventual joint damage. The Disease Activity Score 28 (DAS28) is a widely used tool by healthcare professionals to assess the current activity level of RA in a patient. It considers tender and swollen joint counts (out of 28 specific joints), the patient's global assessment of their disease, and an inflammatory marker like ESR or CRP.
When your doctor refers to "RA low disease activity DAS28," it means your DAS28 score is typically between 2.6 and 3.2. This is a positive outcome, indicating that your RA is well-controlled and less active than it once was. However, it's crucial to understand that 'low disease activity' doesn't mean the disease is gone. You might still experience some symptoms, and consistent management is essential to prevent flares and potential long-term joint damage. The goal is often to achieve remission (DAS28 below 2.6), but low disease activity is a significant step towards that.
Even with low disease activity, treatment remains a cornerstone of RA management. Common medications include Disease-Modifying Antirheumatic Drugs (DMARDs), which work to slow the progression of the disease. These can be conventional synthetic DMARDs like methotrexate, sulfasalazine, hydroxychloroquine, or leflunomide. For some, biologic DMARDs (e.g., adalimumab, etanercept, rituximab) or targeted synthetic DMARDs (e.g., tofacitinib) may be prescribed, especially if conventional options aren't sufficient. Nonsteroidal anti-inflammatory drugs (NSAIDs) or corticosteroids might also be used short-term for symptom relief during occasional flares. These medications, particularly biologics, can be quite costly.
This is where TheDrugClub steps in. We understand that the ongoing cost of RA medications can be a significant burden, even for those with insurance. Our prescription savings membership program helps you reduce your out-of-pocket expenses on both brand-name and generic medications. With a Drug Club membership, you
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.